Adalimumab Biosimilars: Revolutionizing Access to Affordable Biologic Therapies
Biologic therapies have revolutionized the treatment of chronic conditions such as autoimmune and inflammatory diseases. Among these therapies, adalimumab—a TNF-α inhibitor—has emerged as a frontrunner.
